- Report
- January 2019
- 35 Pages
Global
From €965EUR$1,000USD£828GBP
Movantik is a brand of prescription medication used to treat opioid-induced constipation (OIC) in adults with chronic non-cancer pain. It is a peripherally-acting mu-opioid receptor antagonist (PAMORA) that works by blocking the effects of opioids on the gastrointestinal tract. This helps to reduce the symptoms of OIC, such as abdominal pain, bloating, and difficulty passing stools. Movantik is part of a larger market of addiction disorder drugs, which are used to treat a variety of conditions related to substance abuse, including opioid use disorder, alcohol use disorder, and nicotine addiction. These drugs can help to reduce cravings, manage withdrawal symptoms, and prevent relapse.
The addiction disorder drugs market is highly competitive, with a number of major players. These include Purdue Pharma, Reckitt Benckiser, GlaxoSmithKline, Johnson & Johnson, and Novartis. Other companies in the market include Teva Pharmaceuticals, Mylan, and Mallinckrodt Pharmaceuticals. Show Less Read more